Purdue Asks Court To Say No To New Classes In Ch. 11 Case
By Rick Archer (July 16, 2020, 9:58 PM EDT) -- Purdue Pharma asked a New York bankruptcy judge Thursday to reject requests to allow five claims by classes of alleged opioid victims in its Chapter 11 case, saying adding new classes would be an unnecessary, last-minute complication.
Purdue said in its filing that additional class certifications are unnecessary, arguing that the putative class members — schools, hospitals, insurance ratepayers, Native American tribes and the parents of children with neonatal abstinence syndrome, or NAS, a condition caused by neonatal drug withdrawal — are, at this point, on notice of their ability to file individual claims against the drugmaker.
"Their rights, whatever they might...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!